Verify any claim · lenz.io
Claim analyzed
Health“Anemia is one of the most prevalent public health problems in Peru, especially among children under 5 years old.”
Submitted by Brave Bear 64b1
The conclusion
Open in workbench →The evidence strongly supports the claim's core message. Official Peruvian data, WHO/PAHO materials, UNICEF, and peer-reviewed studies consistently show anemia is a major public health problem in Peru, with especially high prevalence among young children, often around one-third to over two-fifths in key under-5 age groups. The wording is broad rather than precisely ranked, but not misleading.
Caveats
- "One of the most prevalent" is a qualitative claim; the sources support importance and widespread prevalence, but do not provide a formal ranking against every other public health problem in Peru.
- Many reported prevalence figures are for narrower child age bands, especially 6–35 months or 6–59 months, not all children under 5 uniformly.
- Reported percentages vary by year, region, and methodology, including altitude-related hemoglobin adjustments, so a single national number should not be treated as fixed.
This analysis is for informational purposes only and does not constitute health or medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making health-related decisions.
Get notified if new evidence updates this analysis
Create a free account to track this claim.
Sources
Sources used in the analysis
Iron-deficiency anemia continues to be a well-known public health problem in Peru. It is prevalent among a large proportion of young children and pregnant women, with previous estimates indicating that almost 30 per cent of children under age five and 21 per cent of women aged 15 to 49 years are anemic. While anemia rates have been decreasing globally, they have remained steady in Peru, even rising in some demographics such as women and children who live in rural or remote areas.
Peru has one of the highest prevalences of anemia among children younger than 5 years of age in South America. The national prevalence of anemia in children younger than 5 years increased from 37.5% in 2011 to 43.6% in 2016. Anemia in children is a major public health problem in Peru and is associated with poverty, chronic malnutrition, and infections.
Currently in Peru, 40.1% of children aged 6 to 35 months suffer from anemia; that is, we are talking about almost 700 thousand children under 3 years old with anemia out of 1.6 million nationwide. This alarming situation has led the current government to set the goal of reducing anemia to 19% by 2021, through the National Plan to fight anemia. The page describes anemia as a serious public health problem that mainly affects children under 3 years of age in Peru.
The Instituto Nacional de Estadística e Informática (INEI) reported that anemia affected 34.9% of children aged 6 to 35 months during 2025, based on results from the Demographic and Family Health Survey (ENDES 2025). During the same year, chronic malnutrition affected 12.1% of children under five years of age, with higher prevalence in rural (21.7%) than urban areas (7.9%). These indicators are presented as "Resultados de los Principales Indicadores de los Programas Presupuestales de la ENDES 2025".
In Peru, anemia is a public health problem, with 34% of children 6–59 months, and 21% of women 15–49 years of age classified as anemic. Significant regional disparities exist as rural children have a higher rate of anemia compared to urban children (53% vs. 40% prevalence, respectively). In Peru’s southern Amazon region of Madre de Dios, Demographic and Health Surveys conducted annually since 2004 have consistently estimated anemia prevalence above 40% in children under 5 years.
A systematic review found that Peru is the country with the second highest prevalence of childhood anemia in Latin America, with a prevalence of 32.9% in children aged less than 5 years. Nationwide, the prevalence of anemia in Peruvian children was 29.47%. Nearly one in three Peruvian children suffer from anemia and it may be extensively explained by wealthiness, as it is distributed among the poorest.
Anaemia is highly prevalent globally, disproportionately affecting children and women of reproductive age. The prevalence of anaemia in a population can be used to classify the public health significance of the problem. For children aged 6–59 months, prevalence of anaemia of 40% or higher is classified as a severe public health problem, 20–39% as a moderate public health problem, and 5–19% as a mild public health problem.
Prevalence of anemia among children (% of children ages 6–59 months) – Peru. This indicator shows the percentage of children aged 6–59 months in Peru with hemoglobin concentration less than 110 g/L, adjusted for altitude. World Bank data indicate that anemia affects a substantial share of Peruvian children under five, with values around one-third of children in recent years.
Infobae reported that the national anemia prevalence in Peru rose to 43.1% among children under three, citing ENDES 2023. The article said Puno remained the region with the highest percentage, at 70.4%.
Data were collected from 578,576 children in the Nutritional Surveillance System in Peru in 2020. Anemia prevalence was estimated in Peruvian children aged 6–59 months living at different altitudes using several adjustment criteria. The total prevalence of anemia varied substantially (from 3.2% to 33.7%) depending on the adjustment criteria used, revealing substantial changes in anemia prevalence among Peruvian children under 5 years of age depending on the hemoglobin adjustment factors for altitude.
In Peru, the prevalence of anemia in children 6 to 35 months according to the Demographic and Family Health Survey (ENDES) 2019 was 40.1%, affecting more those residing in rural areas (49.0%), living in the Sierra region (48.8%) and belonging to the lowest wealth quintile (50.9%). In Peru it has been observed that in the last decade this prevalence has been decreasing, but slowly, because it is still stagnant above 40% and despite great efforts it is still considered an important public health problem. The prevalence of anemia in children under three years of age in Peru is estimated at 40.20% and therefore is still considered a severe public health problem.
The average level of anemia in Peru is 29% in children from 6 to 59 months of age. In Figure 1 it is seen that the prevalence of children with anemia by departments is highest in Puno with 58.0%, followed by Ucayali with 45.1%, Madre de Dios with 43.8%, Cusco with 41.9%, and Huancavelica with 40.9%, while lower percentages are observed in Amazonas (25.2%), Metropolitan Lima (21.3%) and Tacna (20.7%). The study concludes that in children under five years, anemia prevalence is highest in Puno with 58.0%, and that anemia is associated with factors such as maternal education and lack of iron supplementation.
In rural communities of Peru, just over 50% of children from infancy to three years of age suffer from anemia. When the prevalence rate of anemia exceeds 40%, it is recognized as a severe public health problem. In 2013, it was reported that 18.3 percent of children between six and 59 months suffered from moderate anemia, with 0.7 percent suffering from severe anemia.
In general, the tendency of anemia among Peruvian children under 5 years is a decreasing one; at a national level in 2015 it was 44.5% and in 2018 32.3%. Despite this decrease, anemia remains highly prevalent among Peruvian children under five years of age, indicating an important public health concern.
In 2023, 43.1% of boys and girls from 6 to 35 months in Peru were living with anemia, according to the National Demographic and Health Survey (ENDES). This condition mainly affects children under three years of age and pregnant women, and has consequences for their cognitive and motor development, as well as increasing the risk of maternal and perinatal mortality. UNICEF highlights that anemia remains one of the main public health problems in the country, especially in early childhood.
However, in 2024 the prevalence index of anemia in children between 6 and 35 months of age reached 43.7%, an increase of 3.6 percentage points compared to 2021. The note, based on ENDES data, points out the persistence of infant anemia as a public health problem in Peru, with levels above 40% in recent years and significant regional disparities, particularly affecting children under three years of age.
According to official data collected by the ENDES 2025 survey, Peru faces an alarming stagnation in the fight against chronic child malnutrition and anemia. The prevalence of chronic malnutrition in children under 5 years remains at 12.1%, with no change from the previous year, while anemia in children aged 6 to 35 months barely declines from 43.7% to 43.4%, a reduction of only 0.3 percentage points. The article emphasizes that since 2009, when anemia affected 50.4% of children aged 6 to 35 months, the decrease has been slow and discontinuous.
Infant anemia, which affects a high percentage of the child population, showed a notable increase, reaching 43.7% in this age group (children under 3 years). According to ENDES 2024 figures, the national prevalence of anemia in this age group rose from 43.1% in 2023 to 43.7% in 2024. Anemia in children under three years living in rural areas is present in 48.4% of that child population, compared to 36.7% in urban areas.
An article from UPC’s Punto Seguido, citing the Demographic and Family Health Survey (ENDES) of INEI, states that in 2024 the prevalence of anemia and chronic malnutrition in children under five years of age increased to 43.7% and 12.1% nationwide, respectively. It highlights that in rural areas the prevalence of anemia among children 6 to 35 months rose from 50.3% in 2023 to 51.9% in 2024, describing these figures as critical and reflecting a food emergency affecting the child population.
Regarding the prevalence of infant anemia in Peru, the average in children under 3 years is 43.6%, being higher in rural areas (53.3%). At the national level, for rural areas in children 6 to 59 months, the prevalence is 39.5%. The authors state that worldwide, 47.4% of children under five years have some level of anemia, and in Peru the problem is also critical, with high prevalence in young children.
A blog from Universidad San Ignacio de Loyola states that "iron deficiency anemia in children 6 to 59 months – also known as infant iron-deficiency anemia – continues to be one of the main public health problems in Peru." It notes that in 2024, 33.7% of Peruvian children aged 6 to 59 months suffered from anemia, citing MINSA (2025) and indicating that the data source is INEI-ENDES and WHO. The article analyzes anemia (%) in children (6–59 months) by wealth quintile for 2012–2024.
A PDF from the Peruvian Medical Association seminar states that childhood anemia in Peru is a major issue and discusses national prevalence in children under five, but the excerpt provided is largely contextual and less specific than the official statistics above.
The video reports that infant anemia exceeds 43% nationwide, according to the Demographic and Family Health Survey (ENDES). It is mentioned that in some regions such as Puno, anemia rates exceed 50% of children, and that in previous years they even reached more than 70%. The program emphasizes that this is a serious health problem that has increased from 42.4% to 43.1% between 2022 and 2023 in children, affecting their neurological development and leaving lasting consequences.
A Facebook post summarizing ENDES 2025 results states that the survey "alerts stagnation in the fight against anemia and chronic child malnutrition in Peru." It reports that chronic malnutrition in children under 5 years remained at 12.1%, while anemia in girls and boys aged 6 to 35 months only fell from 43.7% to 43.4%, described as a minimal variation compared to the magnitude of the problem. The post emphasizes that the country continues without substantive progress against child malnutrition.
Peru has implemented several national strategies to fight childhood anemia, including iron supplementation programs and fortified foods, in response to the high prevalence of anemia among children under five. These policies reflect that anemia in young children is considered a major public health problem by Peruvian health authorities.
What do you think of the claim?
Your challenge will appear immediately.
Challenge submitted!
For developers
This same pipeline is available via API.
Verify your AI's output programmatically.
/extract pulls claims from text ·
/verify returns sourced verdicts ·
/ask answers follow-up questions.
Continue your research
Verify a related claim next.
Debate
Two AI advocates debated this claim using the research gathered.
Argument for
Multiple highly authoritative sources unanimously confirm that anemia is one of Peru's most serious public health problems, particularly among young children: Source 2 (PAHO/WHO IRIS) explicitly states that 'anemia in children is a major public health problem in Peru,' with national prevalence reaching 43.6% among children under 5 — a level the WHO (Source 7) classifies as a 'severe public health problem.' This is further corroborated by Source 15 (UNICEF Perú), Source 6 (PubMed Central) identifying Peru as having the second highest childhood anemia prevalence in Latin America, and the most recent official government data from Source 4 (INEI) showing 34.9% of children aged 6–35 months still affected in 2025, demonstrating the persistent, widespread nature of this crisis.
The Proponent equivocates between “under‑5” and the narrower 6–35‑month subgroup, then treats older, higher estimates (e.g., the 2016 figure cited in Source 2, PAHO/WHO IRIS) as if they describe the current national situation despite the most recent official ENDES/INEI release placing 2025 prevalence at 34.9% for 6–35 months—below WHO's “severe” ≥40% cutoff (Source 4, Gobierno del Perú–INEI; Source 7, WHO). More fundamentally, the Proponent's “unanimous confirmation” claim ignores that the brief itself documents large measurement sensitivity from altitude-correction choices that can shift national under‑5 prevalence from very low to roughly one‑third (Source 10, PubMed), undermining any confident inference that anemia is definitively among Peru's most prevalent public-health problems rather than a contested, method-dependent estimate.
Argument against
The motion overstates both scope and certainty: official ENDES/INEI reporting puts anemia in children 6–35 months at 34.9% in 2025 (Source 4, Gobierno del Perú–INEI), which is not only below the “severe” ≥40% threshold used to characterize the gravest public-health situations (Source 7, WHO) but also contradicts claims that Peru is uniformly facing an extreme under‑5 anemia crisis. Moreover, the brief itself shows the headline prevalence is highly method-dependent—one large 2020 analysis finds estimates ranging from 3.2% to 33.7% solely from different altitude corrections (Source 10, PubMed)—so asserting anemia is “one of the most prevalent public health problems” (especially under‑5) is not reliably supported by consistent, comparable national measurement.
The Opponent's reliance on the single 2025 ENDES figure of 34.9% to dismiss the severity of Peru's anemia crisis commits a fallacy of selective evidence: the same INEI data coexists with Source 17 (Infobae/ENDES 2025) confirming anemia at 43.4% among children 6–35 months and Source 16 (CEPLAN) recording 43.7% in 2024, while Source 15 (UNICEF Perú), Source 2 (PAHO/WHO IRIS), and Source 11 (SciELO) all independently classify Peru's child anemia burden as a severe public health problem — a consensus that cannot be overturned by one contested data point. Furthermore, the Opponent's invocation of Source 10's altitude-correction variability as grounds for wholesale uncertainty is a methodological red herring: the range cited (3.2%–33.7%) reflects a technical debate about adjustment factors, not a refutation of the underlying disease burden, and even the lower bound of that range still qualifies as a moderate public health problem under WHO's own classification framework in Source 7.
Panel Review
3 specialized AI experts evaluated the evidence and arguments.
Reviewer 1 — The Logic Examiner
The evidence chain from Sources 1-3, 5-9, 11-25 directly establishes high prevalence (30-43%) among children under 5, with explicit classifications by PAHO, UNICEF, INS, and WHO as a major or severe public health problem; this logically entails the claim without overgeneralization. The opponent's selective focus on one 34.9% figure and altitude variability fails to refute the consensus classification, committing cherry-picking and failing to address the direct statements of severity.
Reviewer 2 — The Source Auditor
The most authoritative sources in this pool — PAHO/WHO IRIS (Source 2), the Peruvian government's own INEI (Sources 3, 4), WHO (Source 7), UNICEF Perú (Source 15), PubMed Central (Source 6), Annals of Global Health (Source 5), and CEPLAN (Source 16) — all independently confirm that anemia is a major or severe public health problem in Peru, particularly among children under 5 years old, with prevalence figures ranging from roughly 34% to over 43% depending on age subgroup and year. Even the most recent 2025 ENDES data from INEI (Source 4) shows 34.9% of children aged 6–35 months affected, which WHO's own framework (Source 7) classifies as a moderate-to-severe public health problem, and other 2025 data (Source 17) shows 43.4% for the same age group — the discrepancy likely reflects different measurement windows or reporting conventions. The altitude-correction variability noted in Source 10 is a legitimate methodological caveat but does not undermine the overwhelming consensus from high-authority, independent sources (WHO, PAHO, INEI, UNICEF, peer-reviewed journals) that anemia remains one of Peru's most significant public health challenges for young children, making the claim clearly and robustly supported.
Reviewer 3 — The Precision Analyst
The claim is qualitative ("one of the most prevalent" and "especially" under-5) and the evidence consistently characterizes anemia as a major/important public health problem in Peru with high prevalence among young children, including under-5 or near-under-5 groups (e.g., ~30–44% in multiple sources and explicit "major"/"main" public-health-problem language in Sources 2, 3, 5, 15, and 16). As worded, the claim is supported because it does not assert a specific current percentage or a WHO severity category, and the evidence shows anemia is widespread and repeatedly prioritized as a leading public health problem affecting under-5s, despite some measurement variability and subgroup differences (Sources 4 and 10).